Document Detail


Lethal catatonia responding to high-dose olanzapine therapy.
MedLine Citation:
PMID:  11769826     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We present the case of a 31-year-old woman with recent refractory bipolar disorder who developed a malignant syndrome preceded by catatonic motor features. This resistant case of lethal catatonia responded selectively to high-dose olanzapine treatment. The case illustrates the need to consider lethal catatonia in apparent cases of neuroleptic malignant syndrome that do not respond to conventional treatment with dantrolene and bromocriptine.
Authors:
E M Cassidy; M O'Brien; M F Osman; J Finucane; V O'Keane
Related Documents :
904406 - Mucocutaneous lymph node syndrome: a new clinical entity.
17952296 - Sunct syndrome: report of a possible symptomatic case.
23400356 - Uterine perforation as a complication of surgical abortion causing small bowel obstruct...
16126576 - A case of weil's syndrome developing steroid resistant immune haemolytic anaemia.
10209186 - Sympathetic contralateral vestibulopathy after unilateral zoster oticus.
23411506 - Managing a mandibular second premolar with three-canal and taurodontism: a case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of psychopharmacology (Oxford, England)     Volume:  15     ISSN:  0269-8811     ISO Abbreviation:  J. Psychopharmacol. (Oxford)     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2001-12-24     Completed Date:  2002-05-29     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8907828     Medline TA:  J Psychopharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  302-4     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin. eucass@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / therapeutic use*
Benzodiazepines
Bipolar Disorder / complications
Catatonia / drug therapy*
Electroconvulsive Therapy
Female
Humans
Neuroleptic Malignant Syndrome / drug therapy*
Pirenzepine / analogs & derivatives*,  therapeutic use*
Psychomotor Agitation / drug therapy
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 28797-61-7/Pirenzepine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resista...
Next Document:  Quality assessment of randomized controlled trials of oral implants.